Initital Gleason no guide in salvage therapy

The main message from Karim Fizazi MD PhD is that you should not let the lack of a threatening Gleason grade at initial diagnosis deter you from using abiraterone therapy much later on: there appears to be no relationship at all between initial tumor grade and subsequent response to abiraterone.

Further reading